Coeptis Therapeutics Holdings Inc
COEP
Get informed when a big investor buys or sells
+ FollowMarket Cap$57.35M
Close$
$1.28
90.5% downside
Current Fair Value
90.5% downsideOvervalued by 90.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $57.35 Million |
|---|---|
| Enterprise Value | $52.72 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.81 |
| Beta | -0.43 |
| Outstanding Shares | 6,032,193 |
Return
| Return on Equity | -52.18% |
|---|---|
| Return on Assets | -45.30% |
| Return on Invested Capital | -70.38% |
Valuation & Multiples
| P/E Ratio | -6.61 |
|---|---|
| PEG | 6.84 |
| Price to Sales | - |
| Price to Book Ratio | 4.46 |
| Enterprise Value to Revenue | 37.29 |
| Enterprise Value to EBIT | -4.17 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.17%▲ 0.02% |
|---|---|
| Total Invested | $78,540▼ 21.26% |
| Investors Holding | 10% |
ESG Score
No data
About Coeptis Therapeutics Holdings Inc
5 employees